Стресс-эхокардиография, выполняемая по показаниям, отличным от диагностики ишемии миокарда. Методические рекомендации 2026

Российское кардиологическое общество (РКО)

1. Саидова М. А., Мацкеплишвили С. Т., Козленок А. В. и др. Выполнение, интерпретация результатов и применение стресс-эхокардиографии при ишемической болезни сердца. Методические рекомендации 2026. Российский кардиологический журнал. 2026;31(6S):7104. doi:10.15829/1560-4071-2026-7104. EDN: VLYNQM.

2. Picano E, Pierard L, Peteiro J, et al. The clinical use of stress echocardiography in chronic coronary syndromes and beyond coronary artery disease: a clinical consensus statement from the European Association of Cardiovascular Imaging of the ESC. Eur Heart J Cardiovasc Imaging. 2024;25(2): e65-e90. doi:10.1093/ehjci/jead250.

3. Lancellotti P, Pellikka PA, Budts W, et al. The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(2):101-38. doi:10.1016/j.echo.2016.10.016.

4. Овчинников А. Г., Агеев Ф. Т., Алёхин М. Н. и др. Диа­столическая трансторакальная стресс-эхокардиография с дозированной физической нагрузкой в диагностике сердечной недостаточности с сохраненной фракцией выброса: пока-зания, методология, интерпретация результатов. Кардиология. 2020;60(12):48-63. doi:10.18087/cardio.2020.12.n1219.

5. Nagueh SF, Sun H, Kopelen HA, et al. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol. 2001;37(1):278-85. doi:10.1016/s0735-1097(00)01056-1.

6. Nagueh SF, Sanborn DY, Oh JK, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(7):537-69. doi:10.1016/j.echo.2025.03.011.

7. Luong CL, Anand V, Padang R, et al. Prognostic significance of elevated left ventricular filling pressures with exercise: insights from a cohort of 14,338 patients. J Am Soc Echocardiogr. 2024;37:382-93. doi:10.1016/j.echo.2023.11.012.

8. Ha JW, Andersen OS, Smiseth OA. Diastolic Stress Test: Invasive and Noninvasive Testing. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):272-82. doi:10.1016/j.jcmg.2019.01.037.

9. Merli E, Ciampi Q, Scali MC, et al. Pulmonary congestion during exercise stress echocardiography in ischemic and heart failure patients. Circ Cardiovasc Imaging. 2022;15: e013558.

10. Jambrik Z, Monti S, Coppola V, et al. Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol. 2004;93:1265-70.

11. Scali MC, Zagatina A, Ciampi Q, et al.; Stress Echo 2020 Study Group of the Italian Society of Cardiovascular Imaging. The Functional Meaning of B-Profile During Stress Lung Ultrasound. JACC Cardiovasc Imaging. 2019;12(5):928-30. doi:10.1016/j.jcmg.2018.10.017.

12. Бокерия Л. А., Шляхто Е. В., Габрусенко С. А. и др. Гипертрофическая кардиомиопатия. Клинические рекомендации 2025. Российский кардиологический журнал. 2025;30(5):6387. doi:10.15829/1560-4071-2025-6387. EDN: BUUCJT.

13. Ommen SR, Ho CY, Asif IM, et al.; Peer Review Committee Members. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Car­diology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23): e1239-e1311. doi:10.1161/CIR.0000000000001250. Erratum in: Circulation. 2024;150(8): e198. doi:10.1161/CIR.0000000000001277.

14. Ghazal SN. Valsalva maneuver in echocardiography. J Echocardiogr. 2017;15(1):1-5. doi:10.1007/s12574-016-0310-8.

15. Picano Е. Stress Echocardiography Seventh Edition Springer Cham. 2023. 672p. doi:10.1007/978-3-031-31062-1.

16. Echocardiography by M. K. Rybakova. Moscow: Vidar Publishing House, 2016. 600 p. (In Russ.) Эхокардиография от М. К. Рыбаковой. М.: издательский дом Видар, 2016. 600с, ил.

17. Rowin EJ, Maron BJ, Olivotto I, Maron MS. Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10:1374-86. doi:10.1016/j.jcmg.2017.07.016.

18. Wittlieb-Weber CA, Cohen MS, McBride MG, et al. Elevated LVOT velocities on exercise SE may be a normal physiologic response in healthy youth. J Am Soc Echocardiogr. 2013;26:1372-8.

19. Lazzeroni E, Picano E, Morozzi L, et al. for the Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy. Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult hypertrophic cardiomyo­pathy. Circulation. 1997;96:4268-72.

20. Ciampi Q, Olivotto I, Peteiro J, et al. Prognostic value of reduced heart rate reserve du­ring exercise in hypertrophic cardiomyopathy. J Clin Med. 2021;10:1347.

21. Pálinkás ED, Re F, Peteiro J, et al. Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy. Int J Cardiovasc Imaging. 2022;38: 2593-604.

22. Мацкеплишвили С. Т., Саидова М. А., Мироненко М. Ю. и др. Выполнение стандартной трансторакальной эхокардиографии. Методические рекомендации 2024. Российский кардиологический журнал. 2025;30(2):6271. doi:10.15829/1560-4071-2025-6271. EDN: TNLDFN.

23. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for сardiac сhamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.

24. Алехин М. Н., Бартош-Зеле­ная С. Ю., Берестень Н. Ф. и др. Стандартизация проведения трансторакальной эхокардиографии у взрослых: консенсус экспертов Российской ассоциации специалистов ультразвуковой диагностики в медицине (РАСУДМ) и Российской ассоциации специалистов функциональной диагностики (РАСФД). Ультразвуковая и функциональная диагностика. 2021;(2):63-79. doi:10.24835/1607-0771-2021-2-63-79.

25. Feneon D, Schnell F, Galli E, et al. Impact of exercise-induced mitral regurgitation on hypertrophic cardiomyopathy outcomes. Eur Heart J Cardiovasc Imaging. 2016;17:110-7.

26. Boshchenko AA, Vrublevsky AV, Karpov RS. Transthoracic ultrasound examination of the main coronary arteries. Tomsk: STT; 2015. 240 p. (In Russ.) Бощенко А. А., Вруб­левский А. В., Карпов Р. С. Трансторакальное ультразвуковое исследование магистральных коронарных артерий. Томск: STT; 2015. 240 с. EDN: ZHWICP.

27. Cortigiani L, Rigo F, Gherardi S, et al. Prognostic implications of coronary flow reserve in the left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol. 2008;102:926-32.

28. Nemes A, Balázs E, Soliman OI, et al. Long-term prognostic value of CFVR in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study. Heart Vessel. 2009;24:352-6.

29. Tesic M, Djordjevic-Dikic A, Beleslin B, et al. Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler CFVR analysis. J Am Soc Echocardiogr. 2013;26:775-82.

30. Duncan AM, Francis DP, Gibson DG, Henein MY. Differentiation of ischemic from non-ischemic cardiomyopathy during dobutamine stress by left ventricular long-axis function: additional effect of left bundle branch block. Circulation. 2003;108:1214-20.

31. Pellikka PA, Arruda-Olson A, Chaudhry FA, et al. Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020;33(1):1-41. doi:10.1016/j.echo.2019.07.001.

32. Franchini M, Traversi E, Cannizzaro G, et al. Dobutamine stress echocardiography and thallium-201 SPECT for detecting ischaemic dilated cardiomyopathy in patients with heart failure. Eur J Echocardiogr. 2000;1:109-15.

33. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventri­cular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-8.

34. Velazquez EJ, Lee KL, Jones RH, et al.; STICHES Investigators. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016;374:1511-20.

35. Perera D, Clayton T, O’Kane PD, et al. REVIVEDBCIS2 Investigators. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. N Engl J Med. 2022;387:1351-60.

36. Jourdain P, Funck F, Fulla Y, et al. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol. Eur J Heart Fail. 2002;4:269-76.

37. Packer M, Fowler MB, Roecker EB, et al., Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS)Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194-9.

38. Gupta K, Kakar TS, Gupta A. Role of left ventricle deformation analysis for significant co­ronary artery disease detection. Echocardiography. 2019;36:1084-94.

39. Yoshitani H, Takeuchi M, Mor-Avi V, et al. Comparative diagnostic accuracy of multiplane and multislice three-dimensional dobutamine stress echocardiography in the diagnosis of coronary artery disease. J Am Soc Echocardiogr. 2009;22:437-42.

40. Upton R, Mumith A, Beqiri A, et al. Automated echocardiographic detection of severe coronary artery disease using artificial intelligence. JACC Cardiovasc Imag. 2022;15:715.

41. Praz F, Borger MA, Lanz J, et al.; ESC/EACTS Scientific Document Group. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025: ehaf194. doi:10.1093/eurheartj/ehaf194.

42. Lung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart di­sease II survey. Circulation. 2019;140:1156-69.

43. Lund O, Nielsen TT, Emmertsen K, et al. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg. 1996 6;44:289-95. doi:10.1055/s-2007-1012039.

44. Henri C, Piérard LA, Lancellotti P, et al. Exercise testing and stress imaging in valvular heart disease. Can J Cardiol. 2014;30:1012-26. doi:10.1016/j.cjca.2014.03.013.

45. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26:1309-13. doi:10.1093/eurheartj/ehi250.

46. Redfors B, Pibarot P, Gillam LD, et al. Stress testing in symptomatic aortic stenosis. Circulation. 2017;135:1956-76.

47. Guazzi M, Arena R, Halle M, et al. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2018;39:1144-61. doi:10.1093/eurheartj/ehw180.

48. Hoedemakers S, Pugliese NR, Stassen J, et al. mPAP/CO slope and oxygen uptake add prognostic value in aortic stenosis. Circulation. 2024;149:1172-82. doi:10.1161/CIRCULATIONAHA.123.067130.

49. Lancellotti P, Dulgheru R, Go YY, et al. Stress echocardiography in patients with native valvular heart disease. Heart. 2018;104:807-13. doi:10.1136/heartjnl-2017-311682.

50. Gentry JL III, Phelan D, Desai MY, Griffin BP. The role of stress echocardiography in valvular heart disease: a current appraisal. Cardiology. 2017;137:137-50. doi:10.1159/000460274.

51. Lancellotti P, Magne J. Stress echocardiography in regurgitant valve disease. Circ Cardiovasc Imaging 2013;6:840-9. doi:10.1161/CIRCIMAGING.113.000474.

52. Lancellotti P, Magne J, Donal E, et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation. 2012;126:851-9. doi:10.1161/CIRCULATIONAHA.111.088427.

53. Coisne A, Aghezzaf S, Galli E, et al. Prognostic values of exercise echocardiography and cardiopulmonary exercise testing in patients with primary mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2022;23:1552-61. doi:10.1093/ehjci/jeab231.

54. Rafique AM, Biner S, Ray I, et al. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am J Cardiol. 2009;104:972-7. doi:10.1016/j.amjcard.2009.05.044.

55. Annabi MS, Touboul E, Dahou A, et al. Dobutamine stress echocardiography for ma­nagement of low-flow, low-gradient aortic stenosis. J Am Coll Cardiol. 2018;71:475-85. doi:10.1016/j.jacc.2017.11.052.

56. Lee SY, Park SJ, Kim EK, et al. Predictive value of exercise stress echocardiography in asymptomatic patients with severe aortic regurgitation and preserved left ventricular systolic function without LV dilatation. Int J Cardiovasc Imaging. 2019;35:1241-7.

57. Wahi S, Haluska B, Pasquet A, et al. Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asympto­matic severe aortic regurgitation. Heart. 2000;84:606-14.

58. Vinereanu D, Ionescu AA, Fraser AG. Assessment of left ventricular long-axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart. 2001;85:30-6.

59. Brochet E, Détaint D, Fondard O, et al. Early hemodynamic changes versus peak values: what is more useful to predict occurrence of dyspnea during stress echocardiography in patients with asymptomatic mitral stenosis? J Am Soc Echocardiogr. 2011;24:392-8. doi:10.1016/j.echo.2011.01.006.

60. Zagatina A, Ciampi Q, Peteiro JV, et al.; Stress Echo 2030 study group. Left atrial function during exercise stress echocardiography as a sign of paroxysmal/persistent atrial fibrillation. Cardiovasc Ultrasound. 2024;22(1):13.

61. Bakkestrom R, Banke A, Christensen NL, et al. Hemodynamic characteristics in significant symptomatic and asymptomatic primary mitral valve regurgitation at rest and during exercise. Circ Cardiovasc Imaging. 2018;11: e007171. doi:10.1161/CIRCIMAGING.117.007171.

62. Utsunomiya H, Hidaka T, Susawa H, et al. Exercise-stress echocardiography and effort intolerance in asymptomatic/minimally symptomatic patients with degenerative mitral regurgitation combined invasive-noninvasive hemodynamic monitoring. Circ Cardiovasc Imaging. 2018;11: e007282. doi:10.1161/CIRCIMAGING.117.007282.

63. Lancellotti P, Pibarot P, Chambers J, et al. Multimodality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 2022;23: e171-232. doi:10.1093/ehjci/jeab253.

64. Dhont S, L›Hoyes W, Moura Ferreira S, et al. Atrial Functional Mitral Regurgitation and Exercise-Induced Changes in Heart Failure With Preserved Ejection Fraction. JACC Cardiovasc Imaging. 2025: S1936-878X(25)00449-8. doi:10.1016/j.jcmg.2025.07.016.

65. Sabbag A, Essayagh B, Barrera JDR, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace. 2022;24(12):1981-2003. doi:10.1093/europace/euac125.

66. Suzuki T, Izumo M, Suzuki K, et al. Prognostic value of exercise stress echocardiography in patients with secondary mitral regurgitation: a long-term follow-up study. J Echocardiogr. 2019;17(3):147-56. doi:10.1007/s12574-018-0404-6.

67. Zagatina A, Picano E. Step F for Mitral Regurgitant Flow in Stress Echocardiography. In: Picano, E. (eds) Stress Echocardiography. Springer, Cham. 2023. doi:10.1007/978-3-031-31062-1_6.

68. Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010;122:33-41.

69. Magne J, Pibarot P, Sengupta PP, et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging. 2015;8:83-99.

70. Suzuki K, Izumo M, Yoneyama K, et al. Influence of exercise-induced pulmonary hypertension on exercise capacity in asymptomatic degenerative mitral regurgitation. J Cardiol. 2015;66:246-52.

71. Lee R, Haluska B, Leung DY, et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart. 2005;91:1407-12.

72. Magne J, Mahjoub H, Dulgheru R, et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. Eur Heart J. 2014;35:1608-16.

73. Donal E, Mascle S, Brunet A, et al. Prediction of left ventricular ejection fraction 6 months after surgical correction of organic mitral regurgitation: the value of exercise echocardiography and deformation imaging. Eur Heart J Cardiovasc Imaging. 2012;13:922-30.

74. Lancellotti P, Cosyns B, Zacharakis D, et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr. 2008;21:1331-6.

75. Paraskevaidis IA, Kyrzopoulos S, Tsiapras D, et al. The role of left ventricular long-axis contraction in patients with asymptomatic non-ischemic mitral valve regurgitation and normal systolic function. Int J Cardiol. 2008;124:64-71.

76. Kusunose K, Popovic ZB, Motoki H, Marwick TH. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging. 2013;6(2):167-76.

77. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med. 2003;348:781-90.

78. Refaat MM, Gharios C, Moorthy MV, et al. Exercise-induced ventricular ectopy and cardiovascular mortality in asymptomatic individuals. J Am Coll Cardiol. 2021;78:2267-77.

79. Pibarot P, Dumesnil JG, Jobin J, et al. Usefulness of the indexed effective orifice area at rest in predicting an increase in gradient during maximum exercise in patients with a bioprosthesis in the aortic valve position. Am J Cardiol. 1999;83(4):542-6. doi:10.1016/s0002-9149(98)00910-2.

80. Hobson NA, Wilkinson GA, Cooper GJ, et al. Hemodynamic assessment of mitral mechanical prostheses under high flow conditions: comparison between dynamic exercise and dobutamine stress. J Heart Valve Dis. 2006;15(1):87-91.

81. Bursi F, Picano E. Stress Echocardiography in Valvular Heart Disease. In: Picano, E. (eds) Stress Echocardiography. Springer, Cham. 2023. doi:10.1007/978-3-031-31062-1_34.

82. Авдеев С. Н., Барбараш О. Л., Валиева З. С. и др. Легочная гипертензия, в том числе хроническая тромбоэмболическая легочная гипертензия. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):6161. doi:10.15829/1560-4071-2024-6161. EDN: MYEOVA.

83. Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-731. doi:10.1093/eurheartj/ehac237. Erratum in: Eur Heart J. 2023;44(15):1312. doi:10.1093/eurheartj/ehad005.

84. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685-713.

85. Kusunose K, Yamada H, Nishio S, et al. Pulmonary artery hypertension-specific therapy improves exercise tolerance and outcomes in exercise-induced pulmonary hypertension. JACC Cardiovasc Imag. 2019;12:2576-9.

86. Hamatani Y, Amaki M, Yonezawa R, et al. Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy. Int J Card Imag. 2019;35:837-44.

87. Lim AY, Kim C, Park SJ, et al. Clinical characteristics and determinants of exercise-induced pulmonary hypertension in patients with preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imag. 2017;18:276-83.

88. Tumminello G, Lancellotti P, Lempereur M, et al. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur Heart J. 2007;28:569-74.

89. Borlaug BA, Kane GC, Melenovsky V, Olson TP. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. Eur Heart J. 2016;37:3293-302.

90. Kyranis SJ, Latona J, Platts D, et al. Improving the echocardiographic assessment of pulmonary pressure using the tricuspid regurgitant signal-The "chin" vs the "beard". Echocardiography. 2018;35:1085-96.

91. Ferrara F, Zhou X, Gargani L, et al. Echocardiography in pulmonary arterial hypertension. Curr Cardiol Rep. 2019;21:22. doi:10.1007/s11886-019-1109-9.

92. Baggish AL, Battle RW, Beaver TA, et al. Recommendations on the Use of Multimodality Cardiovascular Imaging in Young Adult Competitive Athletes: A Report from the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance. 2020;33(5):523-49. doi:10.1016/j.echo.2020.02.009.

93. Baggish AL, Battle RW, Beckerman JG, et al. Sports cardiology: core curriculum for providing cardiovascular care to competitive athletes and highly active people. J AmColl Cardiol. 2017;70:1902-18.

94. Cotrim C, Almeida AR, Miranda R, et al. Stress-induced intraventricular gradients in symptomatic athletes during upright exercise continuous wave Doppler echocardiography. Am J Cardiol. 2010;106:1808-12.

95. Kiess A, Vollroth M, Bakhtiary F, et al. Symptomatic myocardial bridging: a frequently occurring coronary variation can cause severe myocardial ischemia in affected children with underlying cardiac conditions. Cardiol Young. 2018;28:826-31.

96. D’Andrea A, Radmilovic J, Russo V, et al. Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis. Eur J Prev Cardiol. 2022;28:1928-38.

97. Hildick-Smith DJ, Johnson PJ, Wisbey CR, et al. Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study. Heart. 2000;84:383-9.

98. Ferrara F, Gargani L, Naeije R, et al., RIGHT Heart International NETwork (RIGHT-NET), et al. Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET). Int J Cardiovasc Imaging. 2021;37:2151-67.

99. Millar LM, Fanton Z, Finocchiaro G, et al. Differentiation between athlete’s heart and dila­ted cardiomyopathy in athletic individuals. Heart. 2020;106:1059-65.

100. Galderisi M, Cardim N, D’Andrea A, et al. The multi-modality cardiac imaging approach to the Athlete’s heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:353.

101. Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873-934. doi:10.1161/CIR.0b013e31829b5b44.

102. van Buuren F, Gati S, Sharma S, et al. Athletes with valvular heart disease and competitive sports: a position statement of the sports cardiology section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28:1569-78.

103. Carbone A, D’Andrea A, Scognamiglio G, et al. Mitral prolapse: an old mysterious entity — the incremental role of multimodality imaging in sports eligibility. J Cardiovasc Echogr. 2018;28:207-17.

104. Claeys M, Claessen G, Claus P, et al. Right ventricular strain rate during exercise accurately identifies male athletes with right ventricular arrhythmias. Eur Heart J Cardiovasc Imaging. 2020;21:282-90.

105. Akhan O, Demir E, Dogdus M, et al. Speckle tracking echocardiography and left ventricular twist mechanics: predictive capabilities for noncompaction cardiomyopathy in the first degree relatives. Int J Cardiovasc Imaging. 2021;37:429-38.